B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

FBP1

MOLECULAR TARGET

fructose-bisphosphatase 1

UniProt: P09467NCBI Gene: 22039 compounds

FBP1 (fructose-bisphosphatase 1) is targeted by 9 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting FBP1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1adenosine phosphate4.1663
2gossypetin2.8316
3Adenosine Monophosphate Adenine nucleotide containing2.6413
4thiram2.4811
5Disulfiram2.309
6bispiperidinylthiocarbonyldisulfide2.208
7benzothiazyl disulfide1.956
8bispyrrolidinylthiocarbonyldisulfide1.956
9tyrphostin ag 14780.691

About FBP1 as a Drug Target

FBP1 (fructose-bisphosphatase 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 9 compounds with documented FBP1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

FBP1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.